Literature DB >> 2154608

Passive immunity to fatal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice.

C F Cuff1, E Lavi, C K Cebra, J J Cebra, D H Rubin.   

Abstract

The role of passively acquired immunity to reovirus-induced meningoencephalitis in neonatal mice was examined. It was determined that female mice were capable of conferring protection against viral infection and meningoencephalitis in neonates depending on the route by which the dams were immunized and the serotype of the immunizing virus. Female mice immunized with homotypic virus via the oral route developed the most potent response. Infected neonates born and nursed by these females developed no signs of disease, and no virus was recoverable from their small intestines, livers, or brains following infection. Neonates born to females immunized with homotypic virus by the subcutaneous route manifested no evidence of meningoencephalitis or virus dissemination, yet virus was recovered from neonatal intestines. Mice immunized with heterotypic virus by either the subcutaneous or the oral route also conferred protection against disease; however, virus was recovered in small intestines and livers of infected neonates. Based on results from foster-nursing experiments, it appears that factors obtained both during suckling and by transplacental transfer contribute to protection. Passive transfer of reovirus-immune mouse serum also protected neonates from disease. These results demonstrate that passive immune mechanisms can mediate the protection of neonates against reovirus infection and provide further evidence of the importance of the mucosal immune response in protection against pathogens that invade the host via mucosal tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154608      PMCID: PMC249241          DOI: 10.1128/JVI.64.3.1256-1263.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  MURINE INFECTION WITH REOVIRUS: I. PATHOLOGY OF THE ACUTE PHASE.

Authors:  M N WALTERS; R A JOSKE; P J LEAK; N F STANLEY
Journal:  Br J Exp Pathol       Date:  1963-08

2.  Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene.

Authors:  R Finberg; H L Weiner; B N Fields; B Benacerraf; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

3.  Reovirus type 3 encephalitis--a virologic and ultrastructural study.

Authors:  C S Raine; B N Fields
Journal:  J Neuropathol Exp Neurol       Date:  1973-01       Impact factor: 3.685

4.  Hydrocephalus in hamsters, ferrets, rats, and mice following inoculations with reovirus type I. I. Virologic studies.

Authors:  L Kilham; G Margolis
Journal:  Lab Invest       Date:  1969-09       Impact factor: 5.662

5.  Evidence for functional domains on the reovirus type 3 hemagglutinin.

Authors:  S J Burstin; D R Spriggs; B N Fields
Journal:  Virology       Date:  1982-02       Impact factor: 3.616

6.  Immunologic tolerance after oral administration of reovirus: requirement for two viral gene products for tolerance induction.

Authors:  D Rubin; H L Weiner; B N Fields; M I Greene
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

7.  Molecular basis of reovirus neurovirulence: role of the M2 gene in avirulence.

Authors:  D B Hrdy; D H Rubin; B N Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines.

Authors:  P W Lee; E C Hayes; W K Joklik
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

9.  The interaction of a series of hybridoma IgGs with reovirus particles. Demonstration that the core protein lambda 2 is exposed on the particle surface.

Authors:  E C Hayes; P W Lee; S E Miller; W K Joklik
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

10.  T lymphocyte immunity to reovirus: cellular requirements for generation and role in clearance of primary infections.

Authors:  N L Letvin; R S Kauffman; R Finberg
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

View more
  13 in total

1.  Enhanced mucosal and systemic immune responses to intestinal reovirus infection in beta2-microglobulin-deficient mice.

Authors:  A S Major; C F Cuff
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates.

Authors:  S B Periwal; T J Speaker; J J Cebra
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis.

Authors:  K L Tyler; M A Mann; B N Fields; H W Virgin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  Predominant T-cell receptor Vbeta usage of intraepithelial lymphocytes during the immune response to enteric reovirus infection.

Authors:  D Chen; F Lee; J J Cebra; D H Rubin
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Effects of the route of infection on immunoglobulin G subclasses and specificity of the reovirus-specific humoral immune response.

Authors:  A S Major; C F Cuff
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches.

Authors:  K J Silvey; A B Hutchings; M Vajdy; M M Petzke; M R Neutra
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Role of immune cells in protection against and control of reovirus infection in neonatal mice.

Authors:  H W Virgin; K L Tyler
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  Antibody is critical for the clearance of murine norovirus infection.

Authors:  Karen A Chachu; David W Strong; Anna D LoBue; Christiane E Wobus; Ralph S Baric; Herbert W Virgin
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

9.  Circulating immunoglobulin G can play a critical role in clearance of intestinal reovirus infection.

Authors:  M L Barkon; B L Haller; H W Virgin
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  3,3'-Diindolylmethane stimulates murine immune function in vitro and in vivo.

Authors:  Ling Xue; James J Pestka; Maoxiang Li; Gary L Firestone; Leonard F Bjeldanes
Journal:  J Nutr Biochem       Date:  2007-08-17       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.